- Other backers included included Investissement Québec, Desjardins Capital, Real Ventures and the Pan-Canadian Consortium MEDTEQ+
- The capital infusion will be used for research and development
- Haleo was founded in 2015
Haleo, a Montreal-based professional virtual sleep clinic, has raised C$5.2 million (US$4.04 million) in seed extension financing. Boréal Ventures and AQC Capital led the round with participation from other backers that included Investissement Québec, Desjardins Capital, Real Ventures and the Pan-Canadian Consortium MEDTEQ+ with support from the Government of Canada. Members of the Anges Québec network and other angel investors also participated in the round.
This seed-funding extension will fuel Haleo’s research and development for new solutions across treatment modalities,such as digital therapeutics, and across underserved clinical fields. Haleo recently launched a new solution for shift workers experiencing insomnia.
Bradley Smith, Haleo founder and CEO said that the company has been focused on delivering outstanding care for sleep at scale since it was founded in 2015. “Everyone’s sleep is different, and so are the organizational cultures of the clients we serve,” he said in a statement. “We personalize care and systematically assess the effectiveness of our interventions for each patient.”
David Charbonneau, managing partner at Boreal Ventures, added that “what sets Haleo apart is how its solution integrates professional clinical expertise in sleep into a digital platform. The result is a seamless clinical experience delivering high engagement, strong adherence to treatment and very satisfied customers.”